5,438 research outputs found

    Thermal conductivity in B- and C- phase of UPt_3

    Full text link
    Although the superconductivity in UPt_3 is one of the most well studied, there are still lingering questions about the nodal directions in the B and C phase in the presence of a magnetic field. Limiting ourselves to the low temperature regime (T<<Delta(0)), we study the magnetothermal conductivity with in semiclassical approximation using Volovik's approach. The angular dependence of the magnetothermal conductivity for an arbitrary field direction should clarify the nodal structure in UPt_3.Comment: 4 pages, 5 figure

    Quasiparticle spectrum of the hybrid s+g-wave superconductors YNi_2B_2C and LuNi_2B_2C

    Full text link
    Recent experiments on single crystals of YNi2_2B2_2C have revealed the presence of point nodes in the superconducting energy gap Delta(k} at k = (1,0,0), (0,1,0), (-1,0,0), and (0,-1,0). In this paper we investigate the effects of impurity scattering on the quasiparticle spectrum in the vortex state of s+g-wave superconductors, which is found to be strongly modified in the presence of disorder. In particular, a gap in the quasiparticle energy spectrum is found to open even for infinitesimal impurity scattering, giving rise to exponentially activated thermodynamic response functions, such as the specific heat, the spin susceptibility, the superfluid density, and the nuclear spin lattice relaxation. Predictions derived from this study can be verified by measurements of the angular dependent magnetospecific heat and the magnetothermal conductivity.Comment: 8 pages, RevTex, 4 figure

    Comprehensive analysis of common serum liver enzymes as prospective predictors of hepatocellular carcinoma in HBV patients.

    Get PDF
    BACKGROUND: Serum liver enzymes are frequently tested in clinics to aid disease diagnosis. Large observational studies indicated that these enzymes might predict cancer risk and mortality. However, no prospective study has reported on their relationships with the risk of HBV-related hepatocellular carcinoma (HCC). METHODOLOGY/PRINCIPAL FINDINGS: We evaluated the predictive values of four routinely tested liver enzymes (alanine aminotransferase [ALT], aspartate aminotransferase [AST], alkaline phosphatase [ALP], and gamma-glutamyltransferase [GGT]) in HCC risk in a prospectively enrolled clinical cohort of 588 Korean American HBV patients. For all four enzymes, the baseline level as well as the average and maximum levels during the first 1 or 2 years of follow-up were analyzed using multivariate Cox proportional hazards model. Patients were categorized into a normal or an elevated group based on the clinical cut-off of each enzyme. During a median follow-up of 7.5 years, 52 patients (incidence rate, 8.8%) developed HCC. The incidence rates were higher in the elevated groups for all four enzymes. The most significant finding was for GGT, with the highest incidence rate of 16.4% in the elevated group compared to 4.6% in the normal group (

    Evaluation of the Effects of Repeat-Dose Dabrafenib on the Single-Dose Pharmacokinetics of Rosuvastatin (OATP1B1/1B3 Substrate) and Midazolam (CYP3A4 Substrate)

    Get PDF
    Dabrafenib; Drug interaction; PharmacokineticsDabrafenib; Interacción de fármacos; FarmacocinéticaDabrafenib; Interacció de fàrmacs; FarmacocinèticaDabrafenib is an oral BRAF kinase inhibitor approved for the treatment of various BRAF V600 mutation–positive solid tumors. In vitro observations suggesting cytochrome P450 (CYP) 3A induction and organic anion transporting polypeptide (OATP) inhibition prompted us to evaluate the effect of dabrafenib 150 mg twice daily on the pharmacokinetics of midazolam 3 mg (CYP3A substrate) and rosuvastatin 10 mg (OATP1B1/1B3 substrate) in a clinical phase 1, open-label, fixed-sequence study in patients with BRAF V600 mutation–positive tumors. Repeat dabrafenib dosing resulted in a 2.56-fold increase in rosuvastatin maximum observed concentration (Cmax), an earlier time to Cmax, but only a 7% increase in area under the concentration-time curve from time 0 (predose) extrapolated to infinite time. Midazolam Cmax and AUC extrapolated to infinite time decreased by 47% and 65%, respectively, with little effect on time to Cmax. No new safety findings were reported. Exposure of drugs that are CYP3A4 substrates is likely to decrease when coadministered with dabrafenib. Concentrations of medicinal products that are sensitive OATP1B1/1B3 substrates may increase during the absorption phase.This study was sponsored by GlaxoSmithKline; dabrafenib and trametinib are assets of Novartis AG as of March 2, 2015

    The magnetic field dependence of the threshold electric field in unconventional charge density waves

    Full text link
    Many experiments suggest that the unidentified low temperature phase (LTP) of alpha-(BEDT-TTF)_2KHg(SCN)_4 is most likely unconventional charge density wave (UCDW). To further this identification we present our theoretical study of the threshold electric field of UCDW in a magnetic field. The magnetic field-temperature phase diagram is very similar to those in a d-wave superconductor. We find a rather strong field dependence of the threshold electric field, which should be readily accessible experimentally.Comment: 7 pages, 6 figure

    Zeeman effects on the impurity-induced resonances in d-wave superconductors

    Full text link
    It is shown how the resonant states induced by a single spinless impurity in a d-wave superconductor evolve under the effect of an applied Zeeman magnetic field. Moreover, it is demonstrated that the spin-orbit coupling to the impurity potential can have important and characteristic effects on the resonant states and their response to the Zeeman field, especially when the impurity is close to the unitary limit. For zero or very small spin-orbit interaction, the resonant states becomes Zeeman splitted by the magnetic field while when the spin-orbit coupling is important, new low-lying resonances arise which do not show any Zeeman splitting.Comment: 5 pages with 5 eps figures embedded. To appear on Phys. Rev.
    • …
    corecore